ID   NCC-LMS1-X3-C1
AC   CVCL_VM07
SY   NCCLMS1X3C1
DR   DepMap; ACH-002786
DR   Wikidata; Q95992532
RX   PubMed=29845452;
WW   Provider; BizCom; -; https://en.cellline.jp/product/ncc-lms1-x3-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft established by subcutaneous injection in female SCID mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo, Tadashi).
CC   Doubling time: 57 hours (PubMed=29845452).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Bone, rib; UBERON=UBERON_0002228.
ST   Source(s): PubMed=29845452
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 9
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C7154; Bone leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LK56 ! NCC-LMS1-C1
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 9
//
RX   PubMed=29845452; DOI=10.1007/s11626-018-0258-2;
RA   Oyama, Rieko
RA   Takahashi, Mami
RA   Kito, Fusako
RA   Sakumoto, Marimu
RA   Shiozawa, Kumiko
RA   Qiao, Zhi-Wei
RA   Yoshida, Akihiko
RA   Endo, Makoto
RA   Kawai, Akira
RA   Kondo, Tadashi
RT   "Establishment and characterization of patient-derived xenograft and
RT   its cell line of primary leiomyosarcoma of bone.";
RL   In Vitro Cell. Dev. Biol. Anim. 54:458-467(2018).
//